Programmed death ligand 2 in cancer-induced immune suppression

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	8 pp
Journal	Clinical and Developmental Immunology
Volume	2012
DOIs	https://doi.org/10.1155/2012/656340
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{286c16dec83441be8cf94a1ea7371e83,

title = "Programmed death ligand 2 in cancer-induced immune suppression",

author = "Esdy Rozali and S.V. Hato and Bruce Robinson and Richard Lake and Willem Lesterhuis",

year = "2012",

doi = "10.1155/2012/656340",

language = "English",

volume = "2012",

pages = "8 pp",

journal = "Clinical and Developmental Immunology",

issn = "1740-2522",

publisher = "Hindawi Limited",

}

TY - JOUR

T1 - Programmed death ligand 2 in cancer-induced immune suppression

AU - Rozali, Esdy

AU - Hato, S.V.

AU - Robinson, Bruce

AU - Lake, Richard

AU - Lesterhuis, Willem

PY - 2012

Y1 - 2012

U2 - 10.1155/2012/656340

DO - 10.1155/2012/656340

M3 - Article

C2 - 22611421

SN - 1740-2522

VL - 2012

SP - 8 pp

JO - Clinical and Developmental Immunology

JF - Clinical and Developmental Immunology

ER -